{{{PM me to join GLOVE Private Discussion Room}}}
I invite you to read my blog and make a smart GLOVE decision.
https://klse.i3investor.com/blogs/gloveharicut/blidx.jsp
I am reproducing the CIMB report to my blog.
Chart | Stock Name | Last | Change | Volume |
---|
2024-11-25
TOPGLOV2024-11-25
TOPGLOV2024-11-25
TOPGLOV2024-11-25
TOPGLOV2024-11-24
SUPERMX2024-11-23
HARTA2024-11-22
HARTA2024-11-22
TOPGLOV2024-11-22
TOPGLOV2024-11-22
TOPGLOV2024-11-21
HARTA2024-11-21
HARTA2024-11-21
HARTA2024-11-20
TOPGLOV2024-11-19
TOPGLOV2024-11-14
HARTA2024-11-14
TOPGLOV2024-11-13
HARTA2024-11-13
HARTA2024-11-13
HARTA2024-11-13
HARTA2024-11-13
HARTA2024-11-13
TOPGLOV2024-11-12
HARTA2024-11-12
HARTA2024-11-12
HARTACreated by gloveharicut | Sep 20, 2022
Created by gloveharicut | Aug 30, 2021
Created by gloveharicut | May 04, 2021
Created by gloveharicut | Apr 19, 2021
u should reconsider switching to Thailand Sri Trang Gloves, half the valuation, no risk of windfall tax, an undiscovered glove gem
2020-08-21 13:47
Bloomberg - Indian tech group withdraws from vaccine race saying not worth it (12:58 p.m. HK) A group of Indian Institute of Technology alumni and academics has withdrawn from the vaccine development race. It’s neither viable nor safe to do such research at a hectic pace and with inadequate data, IIT Alumni Council said in an Aug. 24 statement.
Only 2% of Covid-19 patients need critical care and they can most likely be treated with antibody-based biologics, Daljit Singh, an IIT alumnus and former president at Fortis Healthcare said in the statement.
A vaccine, on the other hand, will need to protect nearly the entire population in order to be effective. “Chasing 2% of the population with a 98% sure cure has a far better probability of success than chasing 98% of the population with a 2% surety of safety and efficacy,” he said.
2020-08-25 15:17
devadra
Any news
2020-08-20 21:21